上市公司财务造假问题研究——以康美药业为例

第1页 / 共15页

第2页 / 共15页

第3页 / 共15页

第4页 / 共15页

第5页 / 共15页

第6页 / 共15页

第7页 / 共15页

第8页 / 共15页
试读已结束,还剩7页,您可下载完整版后进行离线阅读
上市公司财务造假问题研究——以康美药业为例-知知文库网
上市公司财务造假问题研究——以康美药业为例
此内容为付费资源,请付费后查看
10
限时特惠
20
立即购买
您当前未登录!建议登陆后购买,可保存购买订单
付费资源
© 版权声明
THE END
AbstractSince the establishment of China's capital market,it has been constantlyimproving and standardizing,and has established a multi-level capital market systemIn recent years,there have been increasing cases of financial fraud and stock marketfraud in listed companies in China,and the authenticity of the company's book fundshas been questioned constantly.Although some companies have high book profits,they are still unable to repay the due debts and fall into financial difficulties,whicheventually lead to bankruptcy.Therefore,this thesis takes the financial swindle caseof "Kangmei Pharmaceutical Co.,Ltd."as a point of departure,income analyzes themotivation and consequences of financial information fraud of Kangmeipharmaceutical,further explores the causes and means of financial fraud caused byListed Companies in China,and propose relevant means to control financialswindle.Key words:KANGMEI PHARMACEUTICAL CO;Financial fraud;Capital market;Listed company2
喜欢就支持一下吧
点赞0 分享
评论 抢沙发
头像
欢迎您留下宝贵的见解!
提交
头像

昵称

取消
昵称表情代码图片

    暂无评论内容